Leibetseder, Annette
Leitner, Johannes
Mair, Maximilian J.
Meckel, Stephan
Hainfellner, Johannes A.
Aichholzer, Martin
Widhalm, Georg
Dieckmann, Karin
Weis, Serge
Furtner, Julia
von Oertzen, Tim
Preusser, Matthias
Pichler, Josef
Berghoff, Anna Sophie
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 13 May 2021
Revised: 22 July 2021
Accepted: 24 July 2021
First Online: 3 August 2021
Declarations
:
: MP has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen. The following for-profit companies have supported clinical trials and contracted research conducted by MP with payments made to his institution: Böhringer-Ingelheim, Bristol-Myers Squibb, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie. ASB has research support from Daiichi Sankyo (≤ 10,000€), Roche (> 10,000€) and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo (all < 5,000€) as well as travel support from Roche, Amgen and AbbVie. Tim von Oertzen reports grants, personal fees and non-financial support from Novartis Phama, personal fees from Roche Pharma, Biogen Idec Austria, Liva Nova, Arvelle and GW Pharma, grants from Grossegger & Drbal GmbH, grants from Merck, personal fees from Indivior Austria GmbH, personal fees and non-financial support from gtec GmbH Austria, grants and non-financial support from Boehringer-Ingelheim, personal fees from Philips, personal fees and non-financial support from UCB Pharma, personal fees from Almirall, personal fees from Eisai, outside the submitted work; and he is co-chair of the Communication Committee of the European Academy of Neurology (EAN), co-chair of the EAN scientific panel for epilepsy, and president of the Österreichische Gesellschaft für Epileptologie (Austrian ILAE chapter). All other authors report no conflicts of interest related to the study.
: This retrospective chart review study was performed in accordance with the ethical standards of the Ethics Committee of the Medical University of Vienna and Johannes Kepler University Linz (Approval No. 1166/2019 and 1274/2019) and with the Helsinki Declaration of 1964 and its later amendment.
: No informed consent was obtained in accordance with the local ethics committees due to the retrospective design of the study.